Australian Endurance Riders Association (AERA) is disappointed to announce an adverse analytical finding involving prohibited substances at the Mt Cole Endurance Ride held on 1 September 2019. A horse tested positive to the prohibited substance, a controlled medication phenylbutazone, and its metabolite, oxyphenbutazone.
The AERA rules required the disciplinary process to be managed by the member’s Division Association and, in this instance, the person identified as the rider and trainer of the horse is a current member of the Victorian Endurance Riders Association.
The horse, Aldersyde Ambrosia, and rider, Carly Loughnan, have been disqualified from the ride. Ms Loughnan received penalties in accordance with the AERA/EADCM rules, by the imposition of fines, loss of results and associated awards, and requirement to pay costs.
AERA would again remind all persons involved in the sport of endurance to be aware of the risks in campaigning horses who have been given any medications, including any over-the-counter products, and owners should always seek advice from their veterinarians. Consequences can include significant financial penalties.